Working with TipRanks
Follow Us
Stocks
ETFs
Options
Commodities
Crypto
Currency
Pro Newsletters
Research Tools
Calendars
Economic Indicators
Calculators
Education
About Us
Working with TipRanks
Follow Us
Antonius Schuh Insider Profile
4 Followers
Antonius Schuh, CEO, Director at Cardiff Oncology, holds 20.00K shares in Cardiff Oncology (Ticker: CRDF), holds 50.97M shares in Sorrento Therapeutics (Ticker: SRNE). Most recently, Antonius Schuh Bought ― shares of Cardiff Oncology on Aug 12, 2015 for an estimated value of 109.00K.
Antonius Schuh has not reported sufficient informative transactions and therefore cannot be ranked.
Time Frame
Compare to
Insider Holdings
Insider Roles
Roles that Antonius Schuh holds in companies
Most Profitable Insider Trade
The most profitable trade made by Antonius Schuh
Antonius Schuh's Trading History
Cardiff Oncology
Aug 12, 2015
CEO, Director
Informative Buy
109.00K
$46.20K
Sorrento Therapeutics
Sep 22, 2009
Chairman & CEO, Director, Ten Percent Owner
Uninformative Buy
―
$509.69K
List of latest transactions for each holding click on a transaction to see Antonius Schuh's performance on stock
You May Also Like
Antonius Schuh insider profile FAQ
What is the percentage of profitable transactions made by Antonius Schuh?
The percentage of profitable transactions made by Antonius Schuh is ―.
What is the average return per transaction made by Antonius Schuh?
The average return per transaction made by Antonius Schuh is ―.
What stocks does Antonius Schuh hold?
Antonius Schuh holds: CRDF, SRNE stocks.
What was Antonius Schuh’s latest transaction?
Antonius Schuh latest transaction was an Informative Buy of $109.00K.
What was Antonius Schuh's most profitable transaction?
Antonius Schuh’s most profitable transaction was an Informative Buy of CRDF stock on August 12, 2015. The return on the trade was -9.50%.
What is Antonius Schuh's role in Cardiff Oncology?
Antonius Schuh's role in Cardiff Oncology is CEO, Director.
How can I follow the stock ratings of top corporate insiders?
Head over to our Expert Center to see a list of the Top 100 corporate insiders and follow the corporate insiders of your choice. Visit their profiles for more details about their stock transactions and see how they perform on a stock-by-stock basis.